acquired
Stage
1994
Founded
3
Investors
About
Definiens was a German healthtech company that provided image analysis and data mining software solutions for tissue diagnostics and clinical digital pathology. Its technology, known as Tissue Phenomics™, enabled detailed cell-by-cell readouts from tissue slides to improve biomarker identification and support better decisions in research, diagnostics, and therapy.
Explore Definiens's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.